Humacyte, Inc.Long
Humacyte lawsuite is questionable
As a scientist, I have been in medical device development and manufacturing. Every company faces ups and downs in manufacturing medical devices. FDA regularly visits those companies for audits. As an investor, I hired and a FDA compliance expert about two weeks ago to analyze the FDA findings and decide whether I shall sell my shares. According to the expert, the FDA findings were not significant and the issues could have been fixed easily. I humbly think that Humacyte management did not own to it shareholders for disclosing such non-significant and easily fixable nuances. As such, I have been keeping my shares in the stock. My two cents on this topic.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.